Use of a nicotine receptor agonist in the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/455 (2006.01)

Patent

CA 2347855

Use of a nicotine receptor agonist or a pharmaceutically acceptable salt thereof for the production of a pharmaceutical preparation for the treatment of obsessive compulsive disorder is disclosed, as well as a method for treatment of a patient suffering from obsessive compulsive disorder, comprising the administration of a nicotine receptor agonist or a pharmaceutically acceptable salt thereof, in an amount effective in alleviating, reducing or abolishing one or several of the symptoms of obsessive compulsive disorder.

L'invention concerne l'utilisation d'un agoniste du récepteur de nicotine ou d'un sel de ce dernier pharmaceutiquement acceptable pour produire une préparation pharmaceutique destinée au traitement de troubles obsessionnels impulsifs. L'invention concerne également un procédé servant au traitement d'un patient souffrant desdits troubles, qui consiste à lui administrer un agoniste du récepteur de nicotine ou un sel de ce dernier pharmaceutiquement acceptable selon une dose efficace et permettant de soulager, de réduire ou d'éliminer un ou plusieurs symptômes desdits troubles.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of a nicotine receptor agonist in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a nicotine receptor agonist in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a nicotine receptor agonist in the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1863931

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.